Results 211 to 220 of about 88,910 (264)

Partial non‐adherence to antidiabetic therapy undermines diabetes management and correlates with treatment complexity: A cross‐sectional study using blood plasma analysis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate medication adherence in patients with type 2 diabetes (T2D) using plasma drug measurements and assess the clinical impact of partial non‐adherence on glycemic control and complications. Materials and Methods This cross‐sectional study included 641 T2D outpatients attending routine follow‐up visits.
Vojtěch Škop   +9 more
wiley   +1 more source

Antihypertensive Drugs for the Prevention of Atrial Fibrillation: A Drug Target Mendelian Randomization Study. [PDF]

open access: yesHypertension
Geurts S   +8 more
europepmc   +1 more source

Risk of depression with GLP‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The association between glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and depression remains uncertain due to contradictory evidence. We compared the risk of incident depression between GLP‐1 RAs and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) in overweight or obese adults with type 2 diabetes.
Yu Chang   +3 more
wiley   +1 more source

Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco. [PDF]

open access: yesPLOS Glob Public Health
Belayachi S   +7 more
europepmc   +1 more source

Effects of antihypertensive drugs on renal function and atrial natriuretic polypeptide in spontaneously hypertensive rats with renal ablation.

open access: bronze, 1989
Minoru Yasujima   +12 more
openalex   +2 more sources

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle   +3 more
wiley   +1 more source

Enteropathy and intestinal malabsorption in patients treated with antihypertensive drugs. A retrospective cohort study. [PDF]

open access: yesSaudi Med J
Lee SR   +15 more
europepmc   +1 more source

Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Serum 1,5‐anhydroglucitol (1,5‐AG) indicates glycemic control over 1–2 weeks and is particularly useful for monitoring postprandial hyperglycemia. However, its predictive value for long‐term outcomes in type 2 diabetes has not been fully established.
Jiaying Ni   +9 more
wiley   +1 more source

Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Managing blood pressure (BP) in older adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) remains controversial, particularly regarding optimal targets and the impact of inadequate monitoring. Using Clinical Practice Research Datalink (CPRD) data, this study assessed associations between baseline systolic and diastolic BP ...
Anna Meffen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy